Seventy million Americans are eligible to take cholesterol-lowering statins. Yet as many as 20% of outpatients receiving HMG-CoA reductase inhibitors (statins) experience treatment reluctance because of side effects. This leaves a large population at increased risk of cardiovascular disease (CVD). One solution is foods to reduce LDL-C. A study, presentedRead
This study shows a novel method to decrease systolic blood pressure. During this study, published in the European Journal of Preventative Cardiology, participants were exposed to 30 minutes of whole-body blue light at approximately 450 nanometres, a dose comparable to daily sunlight – followed by exposure to a control lightRead
Within the last 2 years, major guidelines have been issued from U.S.-based and European organizations that differ in their recommendations for the diagnosis and treatment of hypertension. In 2017, the American College of Cardiology in United States issued new guidelines for hypertension. They are as follows: In Europe, The TaskRead
It is well known that aspirin can inhibit the aggregation of platelets and reduce the risk of certain cancers such as colorectal cancer, thus the commonly prescribed recommendation of 81mg baby aspirin (one quarter the dose of 325 mg adult aspirin). This Lancet study explored the one-dose-fits all approachRead
Omega-3 intake could be the easiest line of defense for hypertension. New research published in the July edition of Hypertension shows that a high Omega-3 Index — a newly established risk measure for heart disease — is inversely related to blood pressure levels in healthy young adults. This study shedsRead
Response rates to drugs for hypertension are at best 50-50. The reasons are vast including non-compliance, obesity, kidney disease and sleep apnea, A meta-analysis conducted by an international team of sleep and respiratory researchers suggests that untreated sleep apnea may be a major factor in why medications appear to beRead
The commentary published on Today’s Practitioner from Jeffrey Bland PhD and Alex Vasquez, DO was met with widespread interest. In light of the response and the scientific flip flopping regarding Omega-3 fatty acids and coronary disease, it’s important to take retrospective look at a significant 2016 study, Polyunsaturated Fatty AcidRead
Diabetes is five diseases, concludes a new study. By separating adult-onset diabetes cases into five different types, rather than just type 1 or type 2, physicians can better tailor early treatment for patients, and could represent a first step towards precision medicine in the disease, according to an analysis ofRead
In Jan. 2018, the Journal of the American Medical Association published a study, “Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.” The study received a number of negative media reports citing that Omega-3 fatty acids do little to reduce the risk of cardiovascular disease. In response toRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
